TSRI study reveals potential strategy to prevent, treat osteoarthritis during aging
Can't see this email? View it online
   
  Arthritis  
  The latest arthritis news from News Medical  
 

#ALT# PEMF therapy offers drug-free pain relief for RA patients

A review by Ganesan (2009) found that “PEMF not only alleviates the pain in the arthritis condition ... exerts anti-inflammatory action and helps in bone remodeling… this could be developed as a viable alternative for arthritis therapy”.

Read Full Article Here
 
   Key proteins could help in controlling the risk of osteoarthritis during aging, Study findsKey proteins could help in controlling the risk of osteoarthritis during aging, Study finds
 
New study reveals that FOXO proteins help maintain healthy cells in the cartilage of the joints.
 
   TSRI study reveals potential strategy to prevent, treat osteoarthritis during agingTSRI study reveals potential strategy to prevent, treat osteoarthritis during aging
 
More than 30 million Americans suffer from osteoarthritis making it one of the most common age-related diseases.
 
 Researchers discover molecule that enhances cartilage regeneration and curbs inflammation
 
Researchers discover molecule that enhances cartilage regeneration and curbs inflammationWill there come a time when a patient with arthritis can forgo joint replacement surgery in favor of a shot? Keck School of Medicine of USC scientist Denis Evseenko, MD, PhD, has reason to be optimistic.
 
 
 NRAS launches online, interactive program to help people with rheumatoid arthritis
 
NRAS launches online, interactive program to help people with rheumatoid arthritisThis Valentine’s Day, NRAS is delighted to announce the launch of its online, interactive educational program ‘Love your Heart’.
 
 
 Studies find alarming shortage of rheumatology workforce in future
 
Studies find alarming shortage of rheumatology workforce in futureTwo new articles provide insights on the outlook of rheumatology in the United States, noting that the need for rheumatologists will greatly exceed the projected growth of the rheumatology workforce over the next 15 years.
 
 
 New position statement for use of biosimilars to treat rheumatic diseases
 
New position statement for use of biosimilars to treat rheumatic diseasesProducts that are "biosimilar" or interchangeable with a licensed biological product hold considerable promise for the treatment of a variety of medical conditions such as rheumatic diseases, and possibly at a reduced cost.